GlassScriptPhysician profile
Alaa Naim Mansour
NPI 1962885699
$15,655.09
in general payments reported to CMS, 2019-2025
30 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,146 · 2020: $126 · 2021: $1,431 · 2022: $4,038 · 2023: $1,736 · 2024: $2,609 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,584 · Food and Beverage: $2,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,584.14 |
| Food and Beverage | $2,329.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,706.49 | 2020-2024 | Infinity, Prophecy, Prostep |
| Pinnacle, INC | $3,709.68 | 2019-2022 | |
| Crossroads Orthopedics, LLC | $2,554.00 | 2019 | |
| Osteomed LLC | $1,000.00 | 2019 | |
| Depuy Synthes Sales INC. | $954.69 | 2019-2025 | Motoband, Na, Motoband Cp |
| Exactech, INC. | $541.29 | 2019 | |
| Smith+Nephew, INC. | $448.69 | 2019-2025 | Grafix Pl, Stravix, Grafix Xc |
| Wright Medical Technology, INC. | $407.09 | 2019 | |
| Integra Lifesciences Corporation | $188.20 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nevro Corp. | $175.80 | 2022 | |
| Encore Medical, LP | $170.13 | 2025 | Djo Surgical |
| Celularity INC. | $145.00 | 2019 | |
| Bioventus LLC | $141.25 | 2019-2021 | |
| Kerecis Limited | $83.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $42.84 | 2020-2025 | Physio-Stim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $42.08 | 2025 | |
| Solventum Corporation | $41.55 | 2025 | Activ.A.C., Promogran Prisma |
| Zimmer Biomet Holdings, INC. | $39.25 | 2019-2020 | |
| Paragon 28, INC. | $36.96 | 2021-2025 | Silverback |
| Globus Medical, INC. | $33.73 | 2024 | Foot System |
| Abbvie INC. | $29.06 | 2022 | |
| Organogenesis INC. | $26.25 | 2025 | Puraply Wound Matrix |
| Horizon Therapeutics Plc | $25.05 | 2019-2021 | |
| Abbott Laboratories | $23.09 | 2023 | Proclaim |
| Pfizer INC. | $17.89 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.81 | 2024 | Nuzyra |
| Ermi LLC | $15.47 | 2019 | |
| Convatec INC. | $15.08 | 2021 | |
| Grt US Holding, INC. | $12.14 | 2021 | |
| Zyla Life Sciences, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaa Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.